Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection
MJ Van Helden, S Goossens, C Daussy… - Journal of experimental …, 2015 - rupress.org
MJ Van Helden, S Goossens, C Daussy, AL Mathieu, F Faure, A Marçais, N Vandamme…
Journal of experimental medicine, 2015•rupress.org7Institut National de la Santé et de la Recherche Médicale, U1111, 69342 Lyon, France
8Ecole Normale Supérieure de Lyon and 9Centre International de Recherche en
Infectiologie, 69007 Lyon, France 10Centre National de la Recherche Scientifique,
UMR5308, 69342 Lyon, France 11Laboratoire d'Immunologie, Hospices Civils de Lyon,
69495 Lyon, France 12Laboratory of Molecular Biology (Celgen), Department of
Development and Regeneration, KU Leuven, 3000 Leuven, Belgium 13Department of Cell …
8Ecole Normale Supérieure de Lyon and 9Centre International de Recherche en
Infectiologie, 69007 Lyon, France 10Centre National de la Recherche Scientifique,
UMR5308, 69342 Lyon, France 11Laboratoire d'Immunologie, Hospices Civils de Lyon,
69495 Lyon, France 12Laboratory of Molecular Biology (Celgen), Department of
Development and Regeneration, KU Leuven, 3000 Leuven, Belgium 13Department of Cell …
7Institut National de la Santé et de la Recherche Médicale, U1111, 69342 Lyon, France 8Ecole Normale Supérieure de Lyon and 9Centre International de Recherche en Infectiologie, 69007 Lyon, France 10Centre National de la Recherche Scientifique, UMR5308, 69342 Lyon, France 11Laboratoire d’Immunologie, Hospices Civils de Lyon, 69495 Lyon, France 12Laboratory of Molecular Biology (Celgen), Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium 13Department of Cell Biology and 14Department of Pulmonary Medicine, Erasmus MC, 3015 CN Rotterdam, Netherlands 15Centre d'Immunologie de Marseille-Luminy, 13009 Marseille, France 16AltraBio SAS, 69007 Lyon, France 17Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria 3004, Australia
© 2015 van Helden et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www. rupress. or g/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons. org/licenses/by-nc-sa/3. 0/).
rupress.org